A Real Money subscriber emailed me about my thoughts on Beam Therapeutics (BEAM) . The company is exploring a technology called base editing to potentially develop a new class of precision genetic medicines, according to its website. I double majored in economics and finance, so this stuff is above my pay grade.
More from Investing
There are three basic ways to manage luck. The best traders use all three in varying amounts.
While struggles are likely ahead, this is exactly what we need.
When growth starts to slow and inflation moves higher - that's the most unfavorable set of conditions. And that's exactly the market's nervousness right now.